AIPLA

19
AIPLA BIOTECHNOLOGY 2014 Mid-Winter Expo BIOTECHNOLOGY BIOTECHNOLOGY BIOTECHNOLOGY BIOTECHNOLOGY

description

BI O TE C HNOL O GY. BIOTECHN O LOG Y. BIO T ECHNO L OGY. B IOTECH N OLOGY. 2014 Mid-Winter Expo. AIPLA. B I OT E C H NOLO G Y. - PowerPoint PPT Presentation

Transcript of AIPLA

Page 1: AIPLA

AIPLABIOTECHNOLOGY

2014 Mid-Winter ExpoBIOTECHNOLOGYBIOTECHNOLOGYBIOTECHNOLOGYBIOTECHNOLOGY

Page 2: AIPLA

BIOTECHNOLOGY Biotechnology IP practitioners

and companies, however, face very significant challenges in helping the world realize this promise. 

The overall mission of the Biotechnology Committee is to serve as resource, educator, and advocate for its members, AIPLA, government institutions, and people everywhere so that the promise of Biotechnology may be more fully realized globally. 

To realize the promise of Biotechnology in health, energy, environment, and food requires a reliable, global IP system that rewards innovation without inhibiting it and protects investments in new products and new jobs.

Page 3: AIPLA

Chair: Suzannah K. Sundby

Page 4: AIPLA

Vice Chair: Timothy J. Meigs

Page 5: AIPLA

Issues Leader: Vicki G. Norton

Page 6: AIPLA

Academia & Research Institutions Subcommittee

To interface with non-profit academic and research institutions and help educate the biotech community on issues of significant importance to academia and research institutions and promote the interaction, collaboration and sharing of best practices by and between members of the Biotechnology Committee, along with the greater investment, business and legal communities, via meeting workshops, roundtables, webinars or other online communication forums.

Mark BloomSub-Chair

Page 7: AIPLA

Biosimilars SubcommitteeTo monitor patent issues, litigation, and regulations pertinent to the development and commercialization of therapeutic and diagnostic biological products, including biosimilar and interchangeable products, provide the Biotechnology Committee leadership and members with periodic reports, and play a role in advocacy considerations, when pertinent, and coordinate with the Food and Drug Committee in monitoring and reporting on regulatory issues relevant to biological products. Lynn Tyler Kristen

Connarn

Sub-Chairs

Page 8: AIPLA

Biotech Litigation Subcommittee

To disseminate information useful to those litigating biotech patents, including how district courts and the Federal Circuit apply new substantive and procedural law in the biotech area.   

Bryan Diner Carolin Shining

Sub-Chairs

Page 9: AIPLA

Biotech Patent Education Subcommittee

To educate biotech patent practitioners on best practices for planning, obtaining, and leveraging strong patent portfolios for clients in a rapidly-changing legal environment; to serve as a clearing house for ideas on adapting strategies in view of important PTAB, Federal Circuit, and Supreme Court opinions; and to foster the exchange of information and ideas relating to best practices for patent prosecution of inventions in the life sciences. 

Betsy HaanesSub-Chair

Page 10: AIPLA

Plant Biotech SubcommitteeTo foster awareness of competing global interests that affect advances in plant biotechnology, and how intellectual property protection affects those interests; to investigate key patent issues that influence innovative plant research, product development and commercialization; to be a resource for domestic and international patent practitioners who work in plant biotechnology and the patenting of plants; and to advocate for policies that support the promise of plant biotechnology. Alice Martin Bruce Vrana

Sub-Chairs

Page 11: AIPLA

Technology Transfer & Licensing Subcommittee

To define the various licenses and other commercial relationships among industry and institutions, and business considerations that play a primary role in shaping these licenses and relationships; and to advise on trends and best practices and recommend changes in current practices, if needed.

Eric Mirabel Vladimir Drozdoff

Sub-Chairs

Page 12: AIPLA

International Subcommittee

To report on biotech patent issues, laws, and best practices around the world and bring together the global biotech patent community.

Trevor Davies David Read

Sub-Chairs

Page 13: AIPLA

Case Law Reviews Subcommittee

To provide summaries of legal developments relevant to intellectual property that affects biotechnology both in the United States, and worldwide; to include informed commentary that spurs on further discussion; and to provide a simple way for our members to increase their involvement in AIPLA’s work. Nick Landau Melanie

Szweras

Sub-Chairs

HOT BIOTECH Subcommittee

To track important, breaking issues and provide timely “news you can use” updates. Noel CourageSub-ChairIs this YOU?

Page 14: AIPLA

USPTO Relations Subcommittee

To maintain and strengthen the relationship between our members, biotech patent practitioners, and the USPTO, and to increase the quality of biotech patents by monitoring and commenting on USPTO notices, rulemaking, and guidance materials that may impact the protection of inventions in the life sciences.

Joe Mallon Suzannah K. Sundby

Sub-Chairs

Page 15: AIPLA

Liaisons Subcommittee

To establish stronger mutually beneficial relationships with organizations having significant involvement and interests in issues relating to biotechnology and to liaise on various efforts.

James K. Kelley Suzannah K. Sundby

Sub-Chairs

Page 16: AIPLA

Corporate Subcommittee

To meet, connect, collaborate, educate, learn, and enjoy with other biotech practitioners in the corporate realm.

James K. Kelley Is this YOU?Sub-Chair

Past ChairJames K. Kelley

Page 17: AIPLA

To present webinars for the Biotechnology Committee and the general AIPLA membership.

Webinars Subcommittee

Debora Plehn-Dujowich

Sub-Chair

Services LeaderDebora Plehn-

Dujowich

Page 18: AIPLA

To provide more opportunities for our members to network and have fun in local regions.

Social/Regional Subcommittee

Ling Zhong Sub-Chair

Community LeaderLing Zhong

Page 19: AIPLA

Public Communications Subcommittee

To tell the pro-patent innovation story; one that explains the truth so that it can be understood by average citizens and dispel factually incorrect information disseminated by biased parties.

Sub-ChairGene Quinn